- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Pharmacyclics Inc+ Add to Watchlist
PCYC:US257.4500 USD 0.5700 0.22%
As of 20:10:00 ET on 04/17/2015.
Company Profile for Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.
Key Executives for Pharmacyclics Inc (PCYC)
|Robert W Duggan "Bob"Chairman/CEO||Manmeet SoniCFO/Treasurer|
|Mahkam Zanganeh "Maky"Chief Operating Officer||Shawn Cline TomaselloChief Commercial Officer|
|Jesse McGreivyChief Medical Officer||Maria FardisChief:Oncology Ops & Alliances|
|Heow TanChief:Quality Technical Ops||Gregory R WadeExec VP:Business Development|
|Rainer M Erdtmann "Ramses"Senior VP:Investor Relations||Richard Love "Rick"VP/Secretary/General Counsel|
|Matthew D OuttenVP:Commercial Operations|